Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
Banerji, Udai, Prof, van Herpen, Carla M L, Prof, Saura, Cristina, MD, Thistlethwaite, Fiona, MD, Lord, Simon, MD, Moreno, Victor, MD, Macpherson, Iain R, MD, Boni, Valentina, MD, Rolfo, Christian, Prof, de Vries, Elisabeth G E, Prof, Rottey, Sylvie, Prof, Geenen, Jill, MD, Eskens, Ferry, MD, Gil-Martin, Marta, MD, Mommers, Ellen C, PhD, Koper, Norbert P, PhD, Aftimos, Philippe, MD
Published in The lancet oncology (01.08.2019)
Published in The lancet oncology (01.08.2019)
Get full text
Journal Article